Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Regulatory press release

OBSRV: Observe Medical has received first UnoMeterT SafetiT Plus order from the largest UnoMeterT market and has received repeat orders from several countries.

Observe Medical
Oslo, February 28, 2025 - Observe Medical ("the Company" or "Observe Medical")
has received order from the very important UK market that in 2021 represented
more than 40 mNOK of the total UnoMeterT sales.

The first significant deliveries of UnoMeterT SafetiT Plus to the distribution
network started in January, with increasing levels in February, and the revenue
on UnoMeterT SafetiT Plus is picking up accordingly.

Observe medical has received repeat orders from 9 countries and positive
feedback on product performance from end-users across many markets.

Jørgen Mann, CEO of Observe Medical, commented, "Our order intake on UnoMeterT
SafetiT Plus continues to increase and we now have UnoMeterT SafetiT Plus in use
on patients in several market with very positive feedback on product
performance. The input we receive from markets confirms that the market
conditions are favorable as no other competitors have been able to replicate the
product performance of UnoMeterT SafetiT Plus. Our distributors are now out
there converting customers and bidding for tenders, and we expect that the
growth in market share will continue in the coming months".

For further information, please contact:

Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.